Alexander Sumaroka

8.9k total citations · 1 hit paper
103 papers, 6.5k citations indexed

About

Alexander Sumaroka is a scholar working on Molecular Biology, Ophthalmology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Alexander Sumaroka has authored 103 papers receiving a total of 6.5k indexed citations (citations by other indexed papers that have themselves been cited), including 102 papers in Molecular Biology, 76 papers in Ophthalmology and 30 papers in Cellular and Molecular Neuroscience. Recurrent topics in Alexander Sumaroka's work include Retinal Development and Disorders (99 papers), Retinal Diseases and Treatments (73 papers) and Photoreceptor and optogenetics research (28 papers). Alexander Sumaroka is often cited by papers focused on Retinal Development and Disorders (99 papers), Retinal Diseases and Treatments (73 papers) and Photoreceptor and optogenetics research (28 papers). Alexander Sumaroka collaborates with scholars based in United States, Canada and United Kingdom. Alexander Sumaroka's co-authors include Artur V. Cideciyan, Samuel G. Jacobson, Sharon Schwartz, Alejandro J. Román, Tomás S. Alemán, Edwin M. Stone, Elizabeth A. M. Windsor, William W. Hauswirth, Małgorzata Świder and Elise Héon and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Alexander Sumaroka

100 papers receiving 6.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Human gene therapy for RPE65 isomerase deficiency activates the retinoid cycle of vision but with slow rod kinetics

2008 543 citations Artur V. Cideciyan, Tomás S. Alemán et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Alexander Sumaroka United States	46	6.0k	3.5k	1.6k	1.2k	909	103	6.5k
Alejandro J. Román United States	42	5.4k 0.9×	3.0k 0.9×	1.4k 0.9×	1.1k 0.9×	732 0.8×	93	5.8k
Sanford L. Boye United States	46	6.5k 1.1×	2.4k 0.7×	1.6k 1.0×	2.5k 2.0×	685 0.8×	158	7.4k
Tomás S. Alemán United States	59	9.3k 1.5×	5.2k 1.5×	2.4k 1.5×	2.4k 1.9×	1.4k 1.6×	168	10.7k
Shalesh Kaushal United States	31	4.1k 0.7×	1.7k 0.5×	1.2k 0.7×	1.1k 0.9×	649 0.7×	46	4.8k
Mark E. Pennesi United States	37	3.3k 0.5×	2.9k 0.8×	796 0.5×	503 0.4×	1.4k 1.6×	168	5.1k
Robert K. Koenekoop Canada	39	4.5k 0.7×	2.4k 0.7×	748 0.5×	1.3k 1.1×	636 0.7×	119	5.2k
Jijing Pang United States	32	3.6k 0.6×	1.7k 0.5×	978 0.6×	1.2k 1.0×	483 0.5×	78	4.0k
Rob W.J. Collin Netherlands	38	4.5k 0.7×	1.8k 0.5×	758 0.5×	986 0.8×	560 0.6×	138	5.1k
Norman L. Hawes United States	26	3.5k 0.6×	2.0k 0.6×	1.0k 0.6×	694 0.6×	495 0.5×	46	4.3k
Ronald Roepman Netherlands	38	4.8k 0.8×	1.3k 0.4×	702 0.4×	2.1k 1.7×	376 0.4×	92	5.6k

Countries citing papers authored by Alexander Sumaroka

Since Specialization

Citations

This map shows the geographic impact of Alexander Sumaroka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexander Sumaroka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexander Sumaroka more than expected).

Fields of papers citing papers by Alexander Sumaroka

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexander Sumaroka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexander Sumaroka. The network helps show where Alexander Sumaroka may publish in the future.

Co-authorship network of co-authors of Alexander Sumaroka

This figure shows the co-authorship network connecting the top 25 collaborators of Alexander Sumaroka. A scholar is included among the top collaborators of Alexander Sumaroka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexander Sumaroka. Alexander Sumaroka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Świder, Małgorzata, Alexander Sumaroka, Valérie Dufour, et al.. (2024). Retinal response to light exposure in BEST1-mutant dogs evaluated with ultra-high resolution OCT. Vision Research. 218. 108379–108379. 2 indexed citations

Cideciyan, Artur V., Alejandro J. Román, Alexander Sumaroka, et al.. (2024). Inherited Retinal Degeneration Caused by Dehydrodolichyl Diphosphate Synthase Mutation–Effect of an ALG6 Modifier Variant. International Journal of Molecular Sciences. 25(2). 1004–1004. 2 indexed citations

Cideciyan, Artur V., Alejandro J. Román, Raymond L. Warner, et al.. (2024). Evaluation of Retinal Structure and Visual Function in Blue Cone Monochromacy to Develop Clinical Endpoints for L-opsin Gene Therapy. International Journal of Molecular Sciences. 25(19). 10639–10639. 1 indexed citations

Sudharsan, Raghavi, Jennifer Kwok, Małgorzata Świder, et al.. (2024). Retinal prolactin isoform PRLΔE1 sustains rod disease in inherited retinal degenerations. Cell Death and Disease. 15(9). 682–682.

Yang, Paul, Allen C. Ho, Andreas Lauer, et al.. (2024). Safety and efficacy of ATSN-101 in patients with Leber congenital amaurosis caused by biallelic mutations in GUCY2D: a phase 1/2, multicentre, open-label, unilateral dose escalation study. The Lancet. 404(10456). 962–970. 10 indexed citations

Román, Alejandro J., Alexander Sumaroka, Chloë M. Stanton, et al.. (2023). Treatment Strategy With Gene Editing for Late-Onset Retinal Degeneration Caused by a Founder Variant in C1QTNF5. Investigative Ophthalmology & Visual Science. 64(15). 33–33. 1 indexed citations

Jacobson, Samuel G., Artur V. Cideciyan, Allen C. Ho, et al.. (2022). Night vision restored in days after decades of congenital blindness. iScience. 25(10). 105274–105274. 21 indexed citations

Cideciyan, Artur V., Samuel G. Jacobson, Alexander Sumaroka, et al.. (2022). Photoreceptor function and structure in retinal degenerations caused by biallelic BEST1 mutations. Vision Research. 203. 108157–108157. 3 indexed citations

Jacobson, Samuel G., Artur V. Cideciyan, Allen C. Ho, et al.. (2021). Safety and improved efficacy signals following gene therapy in childhood blindness caused by GUCY2D mutations. iScience. 24(5). 102409–102409. 28 indexed citations

10.

Garafalo, Alexandra V., Rebecca Sheplock, Alexander Sumaroka, et al.. (2021). Childhood-onset genetic cone-rod photoreceptor diseases and underlying pathobiology. EBioMedicine. 63. 103200–103200. 5 indexed citations

11.

Garafalo, Alexandra V., Artur V. Cideciyan, Elise Héon, et al.. (2019). Progress in treating inherited retinal diseases: Early subretinal gene therapy clinical trials and candidates for future initiatives. Progress in Retinal and Eye Research. 77. 100827–100827. 129 indexed citations

12.

Sumaroka, Alexander, et al.. (2019). Autosomal Dominant Retinitis Pigmentosa Due to Class B Rhodopsin Mutations: An Objective Outcome for Future Treatment Trials. International Journal of Molecular Sciences. 20(21). 5344–5344. 14 indexed citations

13.

Cideciyan, Artur V., Małgorzata Świder, Valérie Dufour, et al.. (2019). Long-Term Structural Outcomes of Late-Stage RPE65 Gene Therapy. Molecular Therapy. 28(1). 266–278. 58 indexed citations

14.

Aguirre, Geoffrey K., Omar H. Butt, Ritobrato Datta, et al.. (2017). Postretinal Structure and Function in Severe Congenital Photoreceptor Blindness Caused by Mutations in the GUCY2D Gene. Investigative Ophthalmology & Visual Science. 58(2). 959–959. 12 indexed citations

15.

Jacobson, Samuel G., Artur V. Cideciyan, Alexander Sumaroka, et al.. (2017). Outcome Measures for Clinical Trials of Leber Congenital Amaurosis Caused by the Intronic Mutation in the CEP290 Gene. Investigative Ophthalmology & Visual Science. 58(5). 2609–2609. 44 indexed citations

16.

Jacobson, Samuel G., Alexander Sumaroka, Alejandro J. Román, et al.. (2016). Complexity of the Class B Phenotype in Autosomal Dominant Retinitis Pigmentosa Due to Rhodopsin Mutations. Investigative Ophthalmology & Visual Science. 57(11). 4847–4847. 26 indexed citations

17.

Zelinger, Lina, Artur V. Cideciyan, Susanne Kohl, et al.. (2015). Genetics and Disease Expression in the CNGA3 Form of Achromatopsia. Ophthalmology. 122(5). 997–1007. 53 indexed citations

18.

Sadigh, Sam, Xunda Luo, Artur V. Cideciyan, et al.. (2014). Drusen and Photoreceptor Abnormalities in African-Americans with Intermediate Non-neovascular Age-related Macular Degeneration. Current Eye Research. 40(4). 398–406. 17 indexed citations

19.

Cideciyan, Artur V., Rivka A. Rachel, Tomás S. Alemán, et al.. (2011). Cone photoreceptors are the main targets for gene therapy of NPHP5 (IQCB1) or NPHP6 (CEP290) blindness: generation of an all-cone Nphp6 hypomorph mouse that mimics the human retinal ciliopathy. Human Molecular Genetics. 20(7). 1411–1423. 98 indexed citations

20.

Windsor, Elizabeth A. M., et al.. (2005). CRB1– Associated Retinal Degeneration: Macular Pigment and Lutein Supplementation. Investigative Ophthalmology & Visual Science. 46(13). 556–556.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact